Vitex (Chasteberry) for PMS: Benefits, Evidence, Dosing, and Safety

Does Vitex Help Premenstrual Syndrome?

Premenstrual syndrome (PMS) encompasses mood swings, irritability, anxiety, fatigue, breast tenderness, headaches, and bloating. Vitex agnus-castus (chasteberry) has been used for centuries for female reproductive complaints. Its diterpenoids and flavonoids appear to modulate pituitary hormone secretion—reducing prolactin, normalizing luteal-phase progesterone, and balancing estrogen/progesterone ratios.

Scientific Evidence

  • A 2012 Cochrane review found Vitex superior to placebo for global PMS symptoms, but noted small, heterogeneous, low-quality trials.
  • A 2017 systematic review (13 RCTs) reported significant improvement in PMS symptoms (irritability, mood, breast pain, bloating) with Vitex vs. placebo; effect size moderate.
  • Comparative trials: Vitex similar to fluoxetine for PMDD mood symptoms; inferior to combined OCP for physical symptoms.
  • Bottom line: Promising but not definitive. More large, high-quality RCTs needed. Generally well-tolerated.

Dosing and Administration

  • Typical dose: 250–500 mg daily of standardized extract (0.5–1.0% agnuside/casticin), once or twice daily.
  • Forms: Capsules, tablets, liquid extract, tea.
  • Timing: Can be taken throughout cycle or luteal phase only; continuous use often preferred.
  • Onset: May take 2–3 menstrual cycles for full effect. If no improvement after 3 months, reassess.

Side Effects and Interactions

  • Common (mild): Nausea, GI upset, headache, dizziness, acne, menstrual flow changes.
  • Rare: Allergic reactions.
  • Key interactions:
    • Hormonal contraceptives: Vitex may reduce efficacy (dopaminergic/prolactin effects).
    • Dopamine agonists/antagonists (e.g., metoclopramide, antipsychotics): theoretical interaction.
    • Hormone replacement therapy.
    • Fertility medications.

Contraindications

  • Pregnancy and breastfeeding (insufficient safety data; hormonal effects).
  • Hormone-sensitive conditions (breast/ovarian/uterine cancer, endometriosis, uterine fibroids)—theoretical risk.
  • Pituitary disorders.
  • Concurrent dopamine-related medications.

Conclusion

Vitex shows promise for PMS/PMDD with a favorable safety profile for most women. It is not a substitute for medical evaluation of severe symptoms. Consult your healthcare provider before starting, especially if on hormonal medications or with hormone-sensitive conditions.

Genetic Disorders - Related Articles